Publicaciones en colaboración con investigadores/as de Centro de Investigación Cooperativa en Biomateriales (39)

2023

  1. Contribution of APOE Genetic Variants to Dyslipidemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 43, Núm. 6, pp. 1066-1077

2022

  1. Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model

    Small, Vol. 18, Núm. 13

  2. Familial hypercholesterolemia

    Cholesterol: From Chemistry and Biophysics to the Clinic (Elsevier), pp. 501-524

  3. Leu22_Leu23 Duplication at the Signal Peptide of PCSK9 Promotes Intracellular Degradation of LDLr and Autosomal Dominant Hypercholesterolemia

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 42, Núm. 7, pp. E203-E216

2021

  1. (r)HDL in theranostics: How do we apply HDL's biology for precision medicine in atherosclerosis management?

    Biomaterials Science, Vol. 9, Núm. 9, pp. 3185-3208

  2. A systematic approach to assess the activity and classification of pcsk9 variants

    International Journal of Molecular Sciences, Vol. 22, Núm. 24

  3. Fluorine Labeling of Nanoparticles and in Vivo 19F Magnetic Resonance Imaging

    ACS Applied Materials and Interfaces, Vol. 13, Núm. 11, pp. 12941-12949

  4. In vitro cellular uptake studies of self-assembled fluorinated nanoparticles labelled with antibodies

    Nanomaterials, Vol. 11, Núm. 8

  5. MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants

    JACC: Basic to Translational Science, Vol. 6, Núm. 11, pp. 815-827

  6. Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 357-402

2020

  1. Cholesterol efflux efficiency of reconstituted HDL is affected by nanoparticle lipid composition

    Biomedicines, Vol. 8, Núm. 10

  2. In vivo PET Imaging of Gliogenesis After Cerebral Ischemia in Rats

    Frontiers in Neuroscience, Vol. 14

  3. In vivo multimodal imaging of adenosine A1 receptors in neuroinflammation after experimental stroke

    Theranostics, Vol. 11, Núm. 1, pp. 410-425

  4. Pathophysiology of type 2 diabetes mellitus

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-34

  5. Protein-directed crystalline 2D fullerene assemblies

    Nanoscale, Vol. 12, Núm. 6, pp. 3614-3622

  6. Recent developments in the design of non-biofouling coatings for nanoparticles and surfaces

    International Journal of Molecular Sciences, Vol. 21, Núm. 3

  7. Statin treatment-induced development of type 2 diabetes: From clinical evidence to mechanistic insights

    International Journal of Molecular Sciences, Vol. 21, Núm. 13, pp. 1-25

  8. Therapeutic Pretargeting with Gold Nanoparticles as Drug Candidates for Boron Neutron Capture Therapy

    Particle and Particle Systems Characterization, Vol. 37, Núm. 12

  9. Toward Diffusion Measurements of Colloidal Nanoparticles in Biological Environments by Nuclear Magnetic Resonance

    Small, Vol. 16, Núm. 36

2019

  1. Fluorinated CdSe/ZnS quantum dots: Interactions with cell membrane

    Colloids and Surfaces B: Biointerfaces, Vol. 173, pp. 148-154